SF 2154: Relating to the distribution of gene-based vaccines and providing penalties

What it does

This bill relates to the distribution of gene-based vaccines. The bill defines “deoxyribonucleic acid contamination”, “distribute”, “gene-based vaccine”, “shedding”, and “transmission”. The bill requires a manufacturer of gene-based vaccines to conduct integrative transmissibility, deoxyribonucleic acid contamination, and shedding studies prior to the distribution of a gene-based vaccine within the state. The bill provides that any person that distributes a gene-based vaccine within the state posing an unreasonable risk of harm to public health, as determined by the United States food and drug administration, due to transmission or shedding is subject to a $1,000 fine per occurrence and licensing discipline by the appropriate licensing authority, if applicable.

Senate subcommittee · named February 4, 2026

• Sen. Annette Sweeney (R) · annette.sweeney@legis.iowa.gov
• Sen. Janet Petersen (D) · janet.petersen@legis.iowa.gov
• Sen. Scott Webster (R) · scott.webster@legis.iowa.gov

Lobbying · 1 for, 8 against

For: VALOR Iowa

Against: Iowa Biotechnology Association; Iowa Chapter-American Academy of Pediatrics; Iowa Integrated Health Planning and Advisory Council; Iowa Medical Society; Iowa Pharmacy Association; Iowa Public Health Association; Iowa Veterinary Medical Association; Linn County Board of Supervisors

In plain words

1. January 29, 2026Filed in the Senate and sent to the Health and Human Services committee
2. February 4, 2026Senate subcommittee named: Sweeney, Petersen and Webster